152 related articles for article (PubMed ID: 24989923)
41. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
42. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
43. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
44. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?
Ordi J; Alonso I; Torné A; Esteve R; Sierra E; Campo E; Puig-Tintoré LM
Gynecol Oncol; 2005 Nov; 99(2):313-9. PubMed ID: 16112180
[TBL] [Abstract][Full Text] [Related]
46. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
47. The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232107. PubMed ID: 32379782
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
49. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
[TBL] [Abstract][Full Text] [Related]
50. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.
Moss SM; Bailey A; Cubie H; Denton K; Sargent A; Muir P; Vipond IB; Winder R; Kitchener H
Cytopathology; 2015 Dec; 26(6):373-80. PubMed ID: 25274541
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
53. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.
Ronco G; Cuzick J; Segnan N; Brezzi S; Carozzi F; Folicaldi S; Dalla Palma P; Del Mistro A; Gillio-Tos A; Giubilato P; Naldoni C; Polla E; Iossa A; Zorzi M; Confortini M; Giorgi-Rossi P;
Eur J Cancer; 2007 Feb; 43(3):476-80. PubMed ID: 17223540
[TBL] [Abstract][Full Text] [Related]
54. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
55. Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer.
Wang W; Zhang XH; Li M; Hao CH; Zhao ZM; Liang HP
Clin Chim Acta; 2018 Aug; 483():249-255. PubMed ID: 29752912
[TBL] [Abstract][Full Text] [Related]
56. Natural history of persistent high-risk human papillomavirus infections in Korean women.
Bae J; Seo SS; Park YS; Dong SM; Kang S; Myung SK; Park SY
Gynecol Oncol; 2009 Oct; 115(1):75-80. PubMed ID: 19619893
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology.
Origoni M; Carminati G; Rolla S; Clementi M; Sideri M; Sandri MT; Candiani M
Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2401-6. PubMed ID: 22382821
[TBL] [Abstract][Full Text] [Related]
58. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
59. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
[TBL] [Abstract][Full Text] [Related]
60. Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16INK4A expression or human papillomavirus test--a retrospective cohort study.
Chen SF; Yang SF; Chu TY; Lai HC; Lin YW; Bai CY; Nieh S
Gynecol Oncol; 2005 Dec; 99(3):578-84. PubMed ID: 16139346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
